Pricing Log in Create free account

IQVIA Holdings Inc. (IQV) vs Natera, Inc. (NTRA)

IQVIA Holdings Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $52.4B against $43.7B — 1.2× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; IQVIA Holdings Inc. trades at 32.6×. Natera, Inc. grew revenue faster over the last twelve months: 37.4% against 8.85%. IQVIA Holdings Inc. has the higher net margin (8.05% vs −5.66%) and the higher return on invested capital (6.79% vs −8.35%). Across the 20 metrics below, IQVIA Holdings Inc. leads on 15 and Natera, Inc. on 5.

Valuation

Metric IQV NTRA Diagnostics & Research median
P/E 32.63 n/m 35.23
P/S 2.58 15.75 4.08
P/B 6.59 24.50 3.45
Price to free cash flow 21.52 872.96 33.72
EV/EBITDA 16.88 n/m 25.01
EV/Sales 3.37 15.50 5.20
Earnings yield 3.07% (0.36%) (1.47%)
Free cash flow yield 4.65% 0.11% 0.00%

Profitability

Metric IQV NTRA Diagnostics & Research median
Gross margin 33.07% 0.00% 48.32%
Operating margin 12.82% (8.95%) (5.68%)
Net margin 8.05% (5.66%) (4.10%)
Free cash flow margin 12.01% 1.80% 0.00%
Return on equity 21.32% (10.55%) 0.00%
Return on assets 4.71% (7.21%) (6.05%)
Return on invested capital 6.79% (8.35%) 0.00%

Growth

Metric IQV NTRA Diagnostics & Research median
Revenue growth (TTM) 8.85% 37.43% 9.15%
EPS growth (last fiscal year) 4.67% 0.65% 20.36%
Revenue growth, 5-year CAGR 7.50% 42.61% 7.30%
Net income growth, 5-year CAGR 37.27% 0.00% 0.00%

Health

Metric IQV NTRA Diagnostics & Research median
Debt to equity 2.37 0.04 0.04
Current ratio 0.83 2.81 2.27
Net debt to EBITDA 4.06 3.74 0.68

Dividend

Metric IQV NTRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IQV NTRA Diagnostics & Research median
Market cap 43.65b 52.43b 1.93b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack